Six Visionary Teams Are the First to Receive Funding From Breakout Labs, a Thiel Foundation Program to Support Radical Scientific Innovation

Six Visionary Teams Are the First to Receive Funding From Breakout Labs, a Thiel Foundation Program to Support Radical Scientific Innovation
Projects reach for digital brain reconstruction, reversible cryopreservation, human cell re-engineering, universal airborne contaminant detection, artificial protein therapeutics, and antimatter-based fuel

SAN FRANCISCO, Apr 17, 2012 (BUSINESS WIRE) -- The Thiel Foundation announced today the first grants awarded through Breakout Labs, its revolutionary revolving fund to promote innovation in science and technology. Launched in November 2011, Breakout Labs is the Thiel Foundation's newest program; it provides teams of researchers in very early-stage companies with the means to pursue their most radical goals in science and technology. Breakout Labs has awarded six grants, of up to $350,000 each, to the following recipients:

3Scan, to develop 3-D digital reconstruction of brain tissue, using a novel, faster, less expensive microscope technology. Building a map of connections in the brain--the connectome--is a critical step to understanding what makes the human brain unique.

Arigos Biomedical, to develop methods of cooling organs for long-term storage. When combined with emerging advances in cryopreservation, tissue engineering, and stem cell therapies to eliminate graft rejection, this technology would make banked organs immediately available to anyone needing a transplant.

Immusoft, to re-program human immune cells to produce therapeutics in the body. This technology could dramatically improve the ability to treat a range of diseases, as well as enhance human health and longevity.

Inspirotec, to develop a universal system for collecting and identifying virtually any airborne agent. Our environment is increasingly subject to natural and man-made toxins, and this technology would allow for their capture and identification in a simple, low cost handheld device.

Longevity Biotech, to develop an entirely new class of therapeutics via artificial protein technology ("Hybridtides"). Hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures. These features have demonstrated potent therapeutic activity with the possibility of oral biologic delivery.

Positron Dynamics, to enhance the production and collection of positrons, a class of elementary particles. Positrons have many near-term applications, for example, in medical imaging; in the long run, they may be a source of energy--antimatter propulsion--for space travel.

"In the past, people dreamed of the future as a radically better, more technologically advanced place: you might live for centuries, delegate work to your robots, and take your vacations on the moon," said Peter Thiel, who established and funds the Thiel Foundation. "Now, many people expect their children to inherit a world worse than today's. With Breakout Labs, we want to rekindle dreams of an amazing future. That's why we're supporting researchers who dream big and want to build a tomorrow in which we all want to live."

Most of the Breakout Labs grantees have only recently formed companies, conducting research in silico, in technology incubators, with academic collaborators, and through contract research organizations.

"Every week seems to bring the same news: more debt and more layoffs, with most signs of recovery proving ephemeral. America and the world simply cannot recover, much less grow afresh, without remarkably new ideas and companies willing to support them," said Thiel Foundation board member, Ajay Royan. "Our Breakout Labs' recipients are perfect examples of creative entrepreneurs in science and technology that have the passion and vision to change the world."

Breakout Labs accepts applications on a rolling basis. Although the program is open to proposals in any field of advanced science and technology, the current emphasis is on the intersection of biology and technology. Going forward, individual grants will be awarded as proposals emerge from the Breakout Labs' review process.

"We are thrilled with the quality of the applications we have received," said Breakout Labs' Executive Director, Lindy Fishburne. "The initial response to our program has signaled to us that we are addressing a critical gap in the support of early-stage science and technology taking place outside the traditional boundaries of universities and institutions. We look forward to receiving and funding more great proposals throughout the year."

The grantees will be honored at an invitation-only lunch, taking place later today in Fort Mason.

About Breakout Labs

Breakout Labs, the newest program of the Thiel Foundation, does not make typical foundation grants--it is a revolutionary, revolving funding model through which successful projects fund the next generation of daring scientific exploration. Breakout Labs is reshaping the way early-stage science is funded, by providing support for young companies to advance their most radical ideas. Successful grantees will return a modest royalty and warrant stake to Breakout Labs and in this way, contribute to the next generation of scientific innovation. For more information, see www.BreakoutLabs.org .

About the Thiel Foundation

The Thiel Foundation defends and promotes freedom in all its dimensions: political, personal, and economic. The Thiel Foundation supports innovative scientific research and new technologies that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism in all its guises, and encourages the exploration of new ideas and new spaces where people can be less reliant on government and where freedom can flourish. For more information, see ThielFoundation.org.

SOURCE: Thiel Foundation


       
        For Thiel Foundation:
        Ross Gillfillan, +1-415-599-4403
        [email protected]
        Lindy Fishburne, +1-415-376-0355
        [email protected]